Population Frequency Distributions of HDL, HDL2, and HDL3 Cholesterol and Apolipoproteins A-I and B in Healthy Men and Women and Associations with Age, Gender, Hormonal Status, and Sex Hormone Use: The Stanford Five City Project

This publication has 37 references indexed in Scilit:

• Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study
  Circulation, 1996
• HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus
  Circulation, 1995
• Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.
  Circulation, 1994
• Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery Disease
  Annals of Internal Medicine, 1994
• Apolipoproteins and ischaemic heart disease: implications for screening
  The Lancet, 1994
• Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
  Circulation, 1992
• Levels of Lipids, Lipoproteins, and Apolipoproteins in a Defined Population
  Mayo Clinic Proceedings, 1991
• A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
  New England Journal of Medicine, 1991
• Potential for increasing high-density lipoprotein cholesterol, subfractions HDL2-C and HDL3-C, and apoprotein Al among middle-age women
  Preventive Medicine, 1991
• HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.
  Circulation, 1991